High-resolution magnetic resonance imaging of carotid atherosclerotic plaque;Hochauflösende bildgebung atherosklerotischer gefäß wandläsionen der karotiden durch die magnetresonanztomografie

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 180, Issue 2, 2008, Pages 100-111

  Saam, Tobias ^a   Schoenberg, S O ^b   Hatsukami, T S ^c   Reiser, M ^a   Yuan, C ^d   Nikolaou, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum Mannheim gGmbH

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Carotid arteries; MR imaging; Vascular; Vulnerable plaque

Indexed keywords

GLYCOPHORIN A; HEMOSIDERIN;

ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; ENDARTERECTOMY; FIBERSCOPE ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INCIDENCE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; STENT; STROKE; TREATMENT INDICATION; UNITED STATES;

CAROTID ARTERIES; CAROTID ARTERY DISEASES; EQUIPMENT DESIGN; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY;

EID: 39149117048     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963666     Document Type: Review

References (87)

1. Rijbroek A, Wisselink W, Vriens EM et al. Asymptomatic carotid artery stenosis: past, present and future. How to improve patient selection? Eur Neurol 2006; 56: 139-154
2. Rothwell PM. Incidence, risk factors and prognosis of stroke and TIA: the need for high-quality, large-scale epidemiological studies and meta-analyses. Cerebrovasc Dis 2003; 16: 2-10
3. Moore WS, Barnett HJ, Beebe HG et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee. American Heart Association. Circulation 1995; 91: 566-579
4. Gates PC, Chambers B, Yan B et al. Symptomatic and asymptomatic carotid stenosis: just when we thought we had all the answers. Intern Med J 2006; 36: 445-451
5. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke 2000; 31: 774-781
6. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672
7. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772-178
8. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355-1374
9. Virmani R, Kolodgie FD, Burke AP et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275
10. Ambrose JA, Tannenbaum MA, Alexopoulos D et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62
11. Little WC, Constantinescu M, Applegate RJ et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166
12. Fuster V, Stein B, Ambrose JA et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82: II47-II59
13. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671
14. Bassiouny HS, Sakaguchi Y, Mikucki SA et al. Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 1997; 26: 585-594
15. Falk E. Stable versus unstable atherosclerosis: clinical aspects. Am Heart J 1999; 138: S421-S425
16. Yuan C, Mitsumori LM, Beach KW et al. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology 2001; 221: 285-299
17. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci 2000; 902: 173-186
18. Saam T, Kerwin WS, Chu B et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 2005; 7: 799-808
19. Saam T, Hatsukami TS, Yarnykh VL et al. Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging 2007; 26: 344-352
20. Hayes CE, Mathis CM, Yuan C. Surface coil phased arrays for high-resolution imaging of the carotid arteries. J Magn Reson Imaging 1996; 6: 109-112
21. Toussaint JF, Southern JF, Fuster V et al. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1533-1542
22. Yuan C, Murakami JW, Hayes CE et al. Phased-array magnetic resonance imaging of the carotid artery bifurcation: preliminary results in healthy volunteers and a patient with atherosclerotic disease. J Magn Reson Imaging 1995; 5: 561-565
23. Cai J, Hatsukami TS, Ferguson MS et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005; 112: 3437-3444
24. Hatsukami TS, Ross R, Polissar NL et al. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000; 102: 959-964
25. Saam T, Ferguson MS, Yarnykh VL et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005; 25: 234-239
26. Clarke SE, Hammond RR, Mitchell JR et al. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn Reson Med 2003; 50: 1199-1208
27. Shinnar M, Fallon JT, Wehrli S et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol 1999; 19: 2756-2561
28. Koktzoglou I, Chung YC, Mani V et al. Multislice dark-blood carotid artery wall imaging: a 1.5 T and 3.0 T comparison. J Magn Reson Imaging 2006; 23: 699-705
29. Yarnykh VL, Terashima M, Hayes CE et al. Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging 2006; 23: 691-968
30. Yarnykh VL, Yuan C. T1-insensitive flow suppression using quadruple inversion-recovery. Magn Reson Med 2002; 48: 899-905
31. Yarnykh VL, Yuan C. Multislice double inversion-recovery black-blood imaging with simultaneous slice reinversion. J Magn Reson Imaging 2003; 17: 478-483
32. Yuan C, Zhao XQ, Hatsukami TS. Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging. Curr Atheroscler Rep 2002; 4: 351-357
33. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345: 1863-1869
34. Ropers D, Regenfus M, Wasmeier G et al. Non-interventional cardiac diagnostics: computed tomography, magnetic resonance and real-time three-dimensional echocardiography. Techniques and clinical applications. Minerva Cardioangiol 2004; 52: 407-417
35. Deshpande VS, Shea SM, Laub G et al. 3D magnetization-prepared true-FISP: a new technique for imaging coronary arteries. Magn Reson Med 2001; 46: 494-502
36. Bornert P, Stuber M, Botnar RM et al. Direct comparison of 3D spiral vs. Cartesian gradient-echo coronary magnetic resonance angiography. Magn Reson Med 2001; 46: 789-794
37. Katoh M, Stuber M, Buecker A et al. Spin-labeling coronary MR angiography with steady-state free precession and radial k-space sampling: initial results in healthy volunteers. Radiology 2005; 236: 1047-1052
38. Yuan C, Kerwin WS, Yarnykh VL et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006; 19: 636-654
39. Yarnykh VL, Yuan C. Comparison of 2D and 3D black-blood techniques for high-resolution T1-weighted imaging of carotid arteries. Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada 2003: 1632
40. Yuan C, Petty C, O'Brien KD et al. In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids. Arterioscler Thromb Vasc Biol 1997; 17: 1496-1503
41. Mani V, Itskovkh VV, Aguiar SH et al. Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques. J Magn Reson Imaging 2005; 22: 628-633
42. Luo Y, Polissar N, Han C et al. Accuracy and uniqueness of three in vivo measurements of atherosclerotic carotid plaque morphology with black blood MRI. Magn Reson Med 2003; 50: 75-82
43. Kang X, Polissar NL, Han C et al. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn Reson Med 2000; 44: 968-972
44. Eubank WB, Yuan C, Fisher ER et al. Endarterectomy specimen shrinkage: Comparison of T2-weighted MR imaging of specimen ex vivo to histological process. J of Vasc Investigation 1998; 4: 147-152
45. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 2316-2325
46. Chu B, Kampschulte A, Ferguson MS et al. Hemorrhage in the Atherosclerotic Carotid Plaque: A High-Resolution MRI Study. Stroke 2004; 35: 1079-1084
47. Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-3052
48. Cappendijk VC, Cleutjens KB, Heeneman S et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 105-110
49. Takaya N, Yuan C, Chu B et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005; 111: 2768-2775
50. Kampschulte A, Ferguson MS, Kerwin WS et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 2004; 110: 3239-3244
51. Kolodgie FD, Burke AP, Farb A et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285-292
52. Kolodgie FD, Virmani R, Burke AP et al. Pathologic assessment of the vulnerable human coronary plaque. Heart 2004; 90: 1385-1391
53. Redgrave JN, Lovett JK, Gallagher PJ et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006; 113: 2320-2328
54. Devuyst G, Karapanayiotides T, Ruchat P et al. Ultrasound measurement of the fibrous cap in symptomatic and asymptomatic atheromatous carotid plaques. Circulation 2005; 111: 2776-2782
55. Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002; 105: 181-185
56. Chu B, Yuan C, Takaya N et al. Images in cardiovascular medicine. Serial high-spatial-resolution, multisequence magnetic resonance imaging studies identify fibrous cap rupture and penetrating ulcer into carotid atherosclerotic plaque. Circulation 2006; 113: e660-e661
57. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
58. Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003; 107: 851-856
59. Kerwin WS, O'Brien KD, Ferguson MS et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006; 241: 459-468
60. Saam T, Yuan C, Chu B et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 2007; 194: e34-e42
61. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002; 106: 2884-2887
62. Zhao XQ, Yuan C, Hatsukami TS et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 2001; 21: 1623-1629
63. Saam T, Cai JM, Cai YQ et al. Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol 2005; 25: 611-616
64. Saam T, Cai J, Ma L et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006; 240: 464-472
65. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI - initial results. Stroke 2006; 37: 818-823
66. Schmitz SA, Taupitz M, Wagner S et al. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001; 14: 355-361
67. Ruehm SG, Corot C, Vogt P et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415-422
68. Tang T, Howarth SP, Miller SR et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006; 37: 2266-2270
69. Wentzel JJ, Aguiar SH, Fayad ZA. Vascular MRI in the diagnosis and therapy of the high risk atherosclerotic plaque. J Interv Cardiol 2003; 16: 129-142
70. Yu X, Song SK, Chen J et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000; 44: 867-872
71. Flacke S, Fischer S, Scott MJ et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001; 104: 1280-1285
72. Botnar RM, Perez AS, Witte S et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004; 109: 2023-2029
73. Botnar RM, Buecker A, Wiethoff AJ et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004; 110: 1463-1466
74. Spuentrup E, Buecker A, Katoh M et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005; 111: 1377-1382
75. Fenchel M, Jost D, Kramer U et al. Cardiovascular whole-body MR imaging in patients with symptomatic peripheral arterial occlusive disease. Fortschr Röntgenstr 2006; 178: 491-499
76. Neff KW, Kilian AK, Meairs S et al. Correlation of duplex sonographic stenosis grading by means of cross-sectional analysis and MR-tomographic blood volume flow quantification in unilateral stenosis of the internal carotid artery. Fortschr Röntgenstr 2005; 177: 992-999
77. Busch S, Johnson TR, Nikolaou K et al. Visual and automatic grading of coronary artery stenoses with 64-slice CT angiography in reference to invasive angiography. Eur Radiol 2007; 17: 1445-1451
78. Nikolaou K, Knez A, Rist C et al. Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. Am J Roentgenol 2006; 187: 111-117
79. Nikolaou K, Becker CR, Muders M et al. Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries. Atherosclerosis 2004; 174: 243-252
80. Leber AW, Knez A, von Ziegler F et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005; 46: 147-154
81. Becker CR, Knez A, Leber A et al. Initial experiences with multi-slice detector spiral CT in diagnosis of arteriosclerosis of coronary vessels. Radiologe 2000; 40: 118-122
82. Gronholdt ML, Nordestgaard BG, Schroeder TV et al. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73
83. Nissen SE, Tsunoda T, Tuzcu EM et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 2292-2300
84. Nissen SE, Tuzcu EM, Schoenhagen P et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291: 1071-1080
85. Meissner OA, Rieber J, Babaryka G et al. Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens. Fortschr Röntgenstr 2006; 178: 214-220
86. Toussaint JF, LaMuraglia GM, Southern JF et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932-938
87. Serfaty JM, Chaabane L, Tabib A et al. Atherosclerotic plaques: classification and characterization with T2-weighted high-spatial-resolution MR imaging - an in vitro study. Radiology 2001; 219: 403-410